Global Continuous Glucose Monitoring Pioneer Dexcom Reveals New Plans to Bring Sensing Technology to Millions More - DexCom (NASDAQ:DXCM)

New Dexcom product with 15-day wear, a cash-pay option and a tailored software experience for people who don't use insulin is expected to launch in the U.S. in 2024 Access and availability of Dexcom CGM is expanding

Related Keywords

Argentina ,Canada ,United States ,San Diego ,California ,American ,America ,Canadian ,Americans ,Jane Jeffrie Seley ,Nanne Peters ,Hamza Alshannaq ,Lily Chao ,Katia Hannah ,Thomas Martens ,Paul Wadwa ,Jennifer Layne ,Thomas Grace ,Helen Murphy ,Jennifer Sherr ,Celeste Durnwald ,Nicholas Argento ,Kevin Sayer ,Poorva Nemlekar ,Maggie Crawford ,Rayhan Lal ,Centers For Medicare ,Insights Technology ,Diabetes Connections Patient Panel ,Securities Exchange ,Health Disparity ,Scientific Sessions Of The American Diabetes Association ,Dexcom Inc ,Psychosocial Health In People ,National Diabetes Statistics ,Exchange Commission ,Medicaid Services ,New Dexcom ,Scientific Sessions ,American Diabetes Association ,Investor Day ,Urgent Low Soon ,Teri Lawver ,Canadian Perspective ,Medicaid Coverage ,Product Theatre ,Better Adherence ,Real World Glycemic Outcomes ,Using Omnipod ,Glycemic Control ,Extended Use ,Children Ages ,Pregnant Women ,Improved Glycemic Outcomes After ,Sam Bacon ,One Year ,Real World Learnings ,Optimized Care ,Corporate Symposium ,Going Beyond ,Grazia Aleppo ,Athena Philis Tsimikas ,Improved Clinical ,Psychosocial Health ,Basal Insulin ,Perceived Control ,Diabetes Related Hospitalizations ,Medical Costs ,Medicare Advantage Beneficiaries ,Improved Glycemic Control ,Not Treated ,Securities Act ,Securities Exchange Act ,Quarterly Report ,Investor Relations ,Diabetes Statistics Report ,Markets Insights ,Connections Patient Panel ,